High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway

Stem Cells and Development

Volumn 17, Issue 4, 2008, Pages 805-813

  Meng, Erhong ^a   Guo, Zikuan ^a   Wang, Hengxiang ^b   Jin, Jide ^a   Wang, Jinsong ^a   Wang, Hua ^a   Wu, Cutse ^a   Wang, Lisheng ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADVANCED GLYCATION END PRODUCT RECEPTOR; B7 ANTIGEN; BLOCKING ANTIBODY; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD31 ANTIGEN; CD45 ANTIGEN; CONCANAVALIN A; HIGH MOBILITY GROUP B1 PROTEIN; HLA ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; MOLECULAR MARKER; NEUTRALIZING ANTIBODY;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MIGRATION; DOSE RESPONSE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CONCANAVALIN A; CYTOKINES; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; LYMPHOCYTES; MESENCHYMAL STEM CELLS; MITOGENS; OSTEOBLASTS; REGENERATION;

EID: 51849084869     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0276     Document Type: Article

References (50)

1. Muller S, L Ronfani and ME Bianchi. (2004). Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med 255:332-343.
2. Bustin M, DA Lehn and D Landsman. (1990). Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1049:231-243.
3. Scaffidi P, T Misteli and ME Bianchi. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
4. Wang H, O Bloom, M Zhang, JM Vishnubhakat, M Ombrellino, J Che, A Frazier, H Yang, S Ivanova, L Borovikova, KR Manogue, E Faist, E Abraham, J Andersson, U Andersson, PE Molina, NN Abumrad, A Sama and KJ Tracey. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251.
5. Wang H, JM Vishnubhakat, O Bloom, M Zhang, M Ombrellino, A Sama and KJ Tracey. (1999). Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126:389-392.
6. Chen G, J Li, M Ochani, B Rendon-Mitchell, X Qiang, S Susarla, L Ulloa, H Yang, S Fan, SM Goyert, P Wang, KJ Tracey, AE Sama and H Wang. (2004). Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 76:994-1001.
7. Wang H, H Yang, CJ Czura, AE Sama and KJ Tracey. (2001). HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164:1768-1773.
8. Kokkola R, J Li, E Sundberg, AC Aveberger, K Palmblad, H Yang, KJ Tracey, U Andersson and HE Harris. (2003). Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48:2052-2058.
9. Degryse B, T Bonaldi, P Scaffidi, S Muller, M Resnati, F Sanvito, G Arrigoni and ME Bianchi. (2001). The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152:1197-1206.
10. Riuzzi F, G Sorci and R Donato. (2006). The amphoterin (HMGB1/receptor) for advanced glycation end products pair modulates myoblast proliferation, apoptosis, adhesiveness, migration and invasiveenss. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem 281:8242-8253.
11. Palumbo R, M Sampaolesi, F De Marchis, R Tonlorenzi, S Colombetti, A Mondino, G Cossu and ME Bianchi. (2004). Extracel lular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 164:441-449.
12. Tagami K, T Yujiri, A Tanimura, N Mitani, Y Nakamura, K Ariyoshi, T Ando, Y Fujii and Y Tanizawa. (2006). Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation.Br J Haematol 135:567-569.
13. Yang D, Q Chen, H Yang, KJ Tracey, M Bustin and JJ Oppenheim. (2007). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81:59-66.
14. Palumbo R and Bianchi ME. (2004). High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 68:1165-1170.
15. Limana F, A Germani, A Zacheo, J Kajstura, A Di Carlo and G Borsellino. (2005). Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97:e73-83.
16. Mitol a S, M Belleri, C Urbinati, D Coltrini, B Sparatore, M Pedrazzi, E Melloni and M Presta. (2006). Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 176:12-15.
17. Yamada S and I Maruyama. (2007). HMGB1, a novel inflammatory cytokine. Clin Chim Acta 375:36-42.
18. Qin S, H Wang, R Yuan, H Li, M Ochani, K Ochani, M Rosas-Ballina, CJ Czura, JM Huston, E Miller, X Lin, B Sherry, A Kumar, G Larosa, W Newman, KJ Tracey and H Yang. (2006). Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 203:1637-1642.
19. Germani A, Limana F and Capogrossi MC. Pivotal advances: high-mobility group box 1 protein - a cytokine with a role in cardiac repair. (2007). J Leukoc Biol 81:41-45.
20. Kim JB, J Sig Choi, YM Yu, K Nam, CS Piao, SW Kim, MH Lee, PL Han, JS Park and JK Lee. (2006). HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26:6413-6421.
21. Popovic K, M Ek, A Espinosa, L Padyukov, HE Harris, M Wahren-Herlenius and F Nyberg. (2005). Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52:3639-3645.
22. Le Blanc K and Pittenger M. (2005). Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36-45.
23. Izadpanah R, C Trygg, B Patel, C Kriedt, J Dufour, JM Gimble and BA Bunnell. (2006). Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99:1285-1297.
24. da Silva Meirelles L, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213.
25. Guo Z, H Li, X Li, X Yu, H Wang, P Tang and N Mao. (2006). In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived mesenchymal progenitor cells. Stem Cells 24:922-1000.
26. Sakaguchi Y, I Sekiya, K Yagishita and T Muneta. (2005). Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52:2521-2529.
27. in 't Anker PS, WA Noort, SA Scherjon, C Kleijburg-van der Keur, AB Kruisselbrink, RL van Bezooijen, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe. (2003). Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852.
28. Li CD, WY Zhang, HL Li, XX Jiang, Y Zhang, PH Tang and N Mao. (2005). Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res 15:539-547.
29. Weiss ML and DL Troyer. Stem cells in the umbilical cord. (2006). Stem Cell Rev 2:155-162.
30. Zappia E, S Casazza, E Pedemonte, F Benvenuto, I Bonanni, E Gerdoni, D Giunti, A Ceravolo, F Cazzanti, F Frassoni, G Mancardi and A Uccelli. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761.
31. Ishida T, M Inaba, H Hisha, K Sugiura, Y Adachi, N Nagata, R Ogawa, RA Good and S Ikehara. (1994). Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 152:3119-3127.
32. Xu G, L Zhang, G Ren, Z Yuan, Y Zhang, RC Zhao and Y Shi. (2007). Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 17:240-248.
33. Marinova-Mutafchieva L, RO Williams, K Funa, RN Maini, and NJ Zvaifler. (2002). In: ammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 46:507-513.
34. Dimitriou R, E Tsiridis and PV Giannoudis. (2005). Current concepts of molecular aspects of bone healing. Injury 36:1392-1404.
35. Sotnikova NV, LA Stavrova, LA Gur'antseva, TY Khrichkova, TI Fomina, NV Vetoshkina, TY Dubskaya, SA Sergeeva, OI Epshtein, LA Ermolaeva, AM Dygai and ED Gol'dberg. (2005). Mechanisms of the effects of granulocytic CSF on tissue reparation during chronic CCl4-induced damage to the liver. Bull Exp Biol Med 140:644-647.
36. Hellmann MA, H Panet, Y Barhum, E Melamed and D Offen. (2006). Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopaminelesioned rodents. Neurosci Lett 395:124-128.
37. Wu GD, ME Bowdish, YS Jin, H Zhu, N Mitsuhashi, LW Barsky and ML Barr. (2005). Contribution of mesenchymal progenitor cells to tissue repair in rat cardiac allografts undergoing chronic rejection. J Heart Lung Transplant 24:2160-2169.
38. Pevsner-Fischer M, V Morad, M Cohen-Sfady, L Rousso-Noori, A Zanin-Zhorov, S Cohen, IR Cohen and D Zipori. (2007). Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:1422-1432.
39. Guo Z, J Yang, X Liu, X Li, C Hou, PH Tang and N Mao. (2001). Biological features of mesenchymal stem cells from human bone marrow. Chin Med J 114:950-953.
40. Duan HF, Qu CK, Zhang QW, Yu WM, Wang H, Wu CT and Wang LS. (2006). Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblasts. Cell Signal 18:2049-2055.
41. Godfrey WR, MR Krampf, PA Taylor and BR Blazer. (2004). Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood 103:1158-1165.
42. Phinney DG, G Kopen, RL Isaacson and DJ Prockop. (1999). Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72:570-585.
43. Williams JT, SS Southerland, J Souza, AF Calcutt and RG Cartledge. (1999). Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 65:22-26.
44. Adjaye J, J Huntriss, R Herwig, A BenKahla, TC Brink, C Wierling, C Hultschig, D Groth, ML Yaspo, HM Picton, RG Gosden and H Lehrach. (2005). Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells 23:1514-1525.
45. van Beijnum JR, RP Dings, E van der Linden, BM Zwaans, FC Ramaekers, KH Mayo and AW Griffioen. (2006). Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood 108:2339-2348.
46. Balasubramani M, BW Day, RE Schoen and RH Getzenberg. (2006). Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res 66:763-769.
47. Bianchi ME. (2007). DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81:1-5.
48. Yang JP, SHAH, AG Robling, E Templeton, H Yang, KJ Tracey and J Bidwell. (2008). HMGB1 is a bone-active cytokine. J. Cell. Physiol. 214: 730-739.
49. Kume S, S Kato, S Yamagishi, Y Inagaki, S Ueda, N Arima, T Okawa, M Kojiro and K Nagata. (2005). Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 20:1647-1658: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem 97:84-97.
50. Park JS, D Svetkauskaite, H He, J Kim, D Strassheim, A Ishizaka and E Abraham. (2004). Involvement of TLR2 and TLR4 in cellular activation by high mobility group box 1 protein (HMGB1). J Biol Chem 279:7370-7376.